Filana Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Filana Therapeutics, Inc. (FLNA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.44 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-03-26
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-06-30 was 2.22M shares, a 6.29% decline year-over-year.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 2.49M shares, a 2.42% increase year-over-year.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-09-30 was 2.44M shares, a 0.16% increase year-over-year.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 2.37M shares, a 9.06% decline year-over-year.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 7.44M shares, a 37.98% decline from fiscal 2018.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 11.99M shares, a 380.32% increase from fiscal 2017.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 2.50M shares, a 1.52% decline from fiscal 2016.
- Filana Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 2.54M shares, a 85.45% decline from fiscal 2015.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 7.44M shares 10-K · filed 2020-03-26 | |||||||
| 2018-12-31 | 11.99M shares 10-K · filed 2020-03-26 | 11.99M shares 10-K · filed 2019-03-29 | ||||||
| 2018-06-30 | 2.22M shares 10-Q · filed 2018-07-26 | 2.19M shares 10-Q · filed 2018-07-26 | ||||||
| 2018-03-31 | 2.49M shares 10-Q · filed 2018-05-09 | |||||||
| 2017-12-31 | 2.50M shares 10-K · filed 2019-03-29 | 2.50M shares 10-K · filed 2018-02-06 | ||||||
| 2017-09-30 | 2.44M shares 10-Q · filed 2017-11-01 | 2.41M shares 10-Q · filed 2017-11-01 | ||||||
| 2017-06-30 | 2.37M shares 10-Q · filed 2018-07-26 | 2.40M shares 10-Q · filed 2018-07-26 | ||||||
| 2017-03-31 | 2.44M shares 10-Q · filed 2018-05-09 | 17.04M shares 10-Q · filed 2017-04-26 | ||||||
| 2016-12-31 | 2.54M shares 10-K · filed 2018-02-06 | 17.75M shares 10-K · filed 2017-03-07 | ||||||
| 2016-09-30 | 2.43M shares 10-Q · filed 2017-11-01 | 17.02M shares 10-Q · filed 2016-10-26 | 2.56M shares 10-Q · filed 2017-11-01 | 17.96M shares 10-Q · filed 2016-10-26 | ||||
| 2016-06-30 | 2.60M shares 10-Q · filed 2017-08-09 | 18.20M shares 10-Q · filed 2016-07-19 | 2.63M shares 10-Q · filed 2017-08-09 | 18.40M shares 10-Q · filed 2016-07-19 | ||||
| 2016-03-31 | 18.51M shares 10-Q · filed 2017-04-26 | 18.50M shares 10-Q · filed 2016-05-05 | ||||||
| 2015-12-31 | 17.42M shares 10-K · filed 2017-03-07 | 17.40M shares 10-K · filed 2016-03-03 | ||||||
| 2015-09-30 | 16.94M shares 10-Q · filed 2016-10-26 | 16.90M shares 10-Q · filed 2015-11-09 | 17.47M shares 10-Q · filed 2016-10-26 | 17.50M shares 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | 17.70M shares 10-Q · filed 2016-07-19 | 17.70M shares 10-Q · filed 2016-07-19 | ||||||
| 2015-03-31 | 16.90M shares 10-Q · filed 2016-05-05 | 17.80M shares 10-Q · filed 2015-05-08 | ||||||
| 2014-12-31 | 10.63M shares 10-K · filed 2017-03-07 | 10.60M shares 10-K · filed 2015-02-18 | ||||||
| 2014-09-30 | 11.00M shares 10-Q · filed 2015-11-09 | 5.10M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 5.50M shares 10-Q · filed 2015-07-23 | 5.00M shares 10-Q · filed 2015-07-23 | ||||||
| 2014-03-31 | 4.50M shares 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | 13.50M shares 10-K · filed 2016-03-03 | |||||||
| 2013-09-30 | 16.40M shares 10-Q · filed 2014-11-05 | 14.70M shares 10-Q · filed 2014-11-05 | ||||||
| 2013-06-30 | 14.70M shares 10-Q · filed 2014-08-06 | 14.60M shares 10-Q · filed 2014-08-06 | ||||||
| 2013-03-31 | 14.40M shares 10-Q · filed 2014-05-07 | |||||||
| 2012-12-31 | 13.20M shares 10-K · filed 2015-02-18 | |||||||
| 2012-09-30 | 11.80M shares 10-Q · filed 2013-11-01 | 12.20M shares 10-Q · filed 2013-11-01 | ||||||
| 2012-06-30 | 10.20M shares 10-Q · filed 2012-08-02 | |||||||
| 2011-12-31 | 13.70M shares 10-K · filed 2014-02-05 | |||||||
| 2011-06-30 | 5.10M shares 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |